Commercialization: Page 44

PharmaVoice Team/PharmaVoice

Dynamic Strategic Outsourcing and New Commercial Paradigms: Benefits of Changing The Fixed-to-variable Ratio

Biopharmaceutical companies’ commercial paradigms must respond to an ever-changing marketplace, with increasing demands from both payers and patients for better care, improved outcomes, more affordable therapies, and increased speed to market. In a recent interview, George Esgro, Vice President &...
By George Esgro • Feb. 1, 2015
PharmaVoice Team/PharmaVoice

Pharmaceutical Call Centers Build Relationships and Improve Outcomes

As communication channels expand, field-based sales representatives will be pivotal in coordinating communications with HCPs to support educational needs and ensure value is delivered no matter which channel is used. Life-sciences companies have a significant need to build relationships with heal...
By Lou Shapiro • Feb. 1, 2015
PharmaVoice Team/PharmaVoice

Letter from the Editor

Cancer — Impacts Us All In 2014, there were an estimated 1,665,540 new cancer cases diagnosed and 585,720 cancer deaths in the United States alone. Cancer remains the second-most common cause of death in the United States, accounting for almost one of every four deaths. While usually lumped under...
By Taren Grom • Jan. 1, 2015
PharmaVoice Team/PharmaVoice

UpFront

The Amgen Foundation Expands Amgen Scholars Program The Amgen Scholars Program is expanding its presence with new host institutions in the United States, Europe, and, for the first time, Japan. The Amgen Scholars Program aims to inspire the next generation of innovators by providing undergraduate...
By Denise Myshko • Jan. 1, 2015
PharmaVoice Team/PharmaVoice

Innovator's Corner

From Smart Pills to Digital Medicines Markus Christen, Ph.D., Senior VP, Global Development, Proteus Digital Health, ?talks about the company’s smart pill technology, which has the potential to lead to a new therapeutic category of products: digital medicines. Digital technology is transforming j...
By Markus Christen • Jan. 1, 2015
PharmaVoice Team/PharmaVoice

The Network

Using Digital Across the Spectrum to Improve Care Trending Now: Patients, especially millennials, are open to online healthcare engagement. NPR Study Shows Americans -Willing to Share Health Data, ?with a Caveat A new study from NPR and Truven Health Analytics of 3,000 Americans shows that there ...
By Taren Grom • Jan. 1, 2015
PharmaVoice Team/PharmaVoice

Tools of the Trade

Pharma Companies Help Shape Accenture Life Sciences Cloud for R&D Trending Now: Eisai, Merck, and Pfizer join with Accenture to build a standards-driven platform ?powered by Oracle to help simplify and speed drug development. Accenture has launched Accenture Life Sciences Cloud for R&D, w...
By Denise Myshko • Jan. 1, 2015
PharmaVoice Team/PharmaVoice

Pharma Trax

Sales, marketing, And R&D?Trends affecting the healthcare industry Pharma Companies Not Ready for Personalized Medicine Trending Now: Janssen, Roche, and Novartis are disrupters in personalized medicine and ?have demonstrated the ability to competitively reshape therapeutic areas. Leading ph...
By Denise Myshko • Jan. 1, 2015
PharmaVoice Team/PharmaVoice

Talent Pool

Executive appointments and promotions in the healthcare industry Pharma Pool Stephen Aselage Retrophin Appoints CEO Retrophin has appointed Stephen Aselage as CEO; he has served as the company’s interim CEO since Sept. 30, 2014. Mr. Aselage has more than 30 years of pharmaceutical and biotechnolo...
By PharmaVoice Team • Jan. 1, 2015
PharmaVoice Team/PharmaVoice

Where Have All The Sales Reps Gone?

The death of the pharma sales rep has been greatly exaggerated, however, the role of the sales rep is headed for big changes. Healthcare providers are choosing multiple channels to receive their information on pharma products, which could lead to the assumption that pharma sales reps could soon b...
By Robin Robinson • Jan. 1, 2015
PharmaVoice Team/PharmaVoice

Using Consumer Data In R&D

Consumer and personal health data will play a larger role in clinical research in the future. More and more data relevant to health are being captured by consumers and patients through patient diaries, monitoring devices, and health and fitness tracking diaries, and apps. Patient and consumer dat...
By Denise Myshko • Jan. 1, 2015
PharmaVoice Team/PharmaVoice

Track And Trace: Preparing For DSCSA Implementation

The first deadline of the 10-year DSCSA Implementation Plan takes effect this month, and experts say many drug manufacturers are not ready. The Drug Supply Chain Security Act (DSCSA) Implementation Plan regulation, which began phasing in on Jan. 1, 2015, provides a national policy for combating c...
By Robin Robinson • Jan. 1, 2015
PharmaVoice Team/PharmaVoice

South Korea

Proven R&D capabilities, a strong regulatory system, government support, and a wealth of talent are among the factors that draw pharma companies to South Korea. South Korea, or the Republic of Korea, is an industrialized nation with a strong standing on the world stage. It was the first Asian...
By Kim Ribbink • Jan. 1, 2015
PharmaVoice Team/PharmaVoice

SHOWCASE FEATURE: Social Media: A Social Revolution

As pharmaceutical companies continue to dabble in social media, patients and consumers are not waiting, and are in fact, driving health-related conversations in a variety of ways and across a variety of media, most importantly digital. A recent study found that one-quarter of the world’s populati...
By Taren Grom • Jan. 1, 2015
PharmaVoice Team/PharmaVoice

Making Better Connections With Context

Our involvement in social media requires thoughtful planning; predetermined and approved frameworks; rules of engagement, content workflows, and efficient approval workflows; monitoring technologies; legal guidelines; and integrated QA processes. My job, probably yours too, is to connect HCPs a...
By Ben Currie • Jan. 1, 2015
PharmaVoice Team/PharmaVoice

Making Social Count: How Mobile and Data Help Social Media Reach Their Potential

For years, pharmaceutical marketers have talked about moving “beyond the pill." We know our work needs to provide patients with tools and services to help manage and improve their health, in concert with — or even instead of — our prescription brands. We’ve exhorted each other to not be satisfie...
By Sarah Morgan • Jan. 1, 2015
PharmaVoice Team/PharmaVoice

Social Media Has Revolutionized The Healthcare Industry

The marketing function of the pharmaceutical industry needs to begin focusing on changing its thinking around social media, to more of an -engagement-oriented model and less around advertising and promotion. Social should be viewed as an integral part of the overall marketing mix and not silo’d o...
By Ritesh Patel • Jan. 1, 2015
PharmaVoice Team/PharmaVoice

Detangling Oncology

Oncology is expected to be the biggest therapeutic class by 2017. In this first article in an ongoing series addressing various aspects involved with oncology, experts examine the market drivers, research highlights, and marketing, sales, and payer considerations of this market. In 2014, there we...
By PharmaVoice Team • Jan. 1, 2015
PharmaVoice Team/PharmaVoice

Disruptive Technology: The Keys to Pharmaceutical Innovation

New technologies will drive innovation in the pharmaceutical industry in the years to come. The ability to innovate, industry leaders agree, will be a critical factor in a pharmaceutical company’s success in the future. Companies will have to embrace scientific advances and technologies to move n...
By PharmaVoice Team • Nov. 15, 2014
PharmaVoice Team/PharmaVoice

Personalized Medicine: Personalized Medicine Gains Momentum

Personalized and precision medicines have the potential to change the way we think about, identify, and manage healthcare. In the years since the completion of the Human Genome Project, advances in genome technology have led to an exponential decrease in sequencing costs. This has led to more tha...
By PharmaVoice Team • Nov. 15, 2014
PharmaVoice Team/PharmaVoice

Payers: Addressing the Needs of Payers

Helping payers contain costs and improve outcomes becomes paramount for pharma in the healthcare reform future. According to an EY report, the majority of payers in the United States and Europe believe that drug adherence solutions and data that pharma companies possess are vital to lowering heal...
By PharmaVoice Team • Nov. 15, 2014
PharmaVoice Team/PharmaVoice

Patient-Centricity: The Power of the Patient

As patients move from recipients to participants, the industry needs to align strategies to pull them into the focus of future business models. A recent PwC report describes a new health economy on the horizon, one in which technological advances, empowered consumers, disruptive new entrants, and...
By PharmaVoice Team • Nov. 15, 2014
PharmaVoice Team/PharmaVoice

Specialty Pharma: Specialty Pharma on the Rise

v According to Express Scripts, more than one-third of all specialty drugs currently in development — and there are nearly 900 of them — target cancer and related conditions, which is by far the most concentrated area of research. But specialty drugs manage many other complex, chronic conditions,...
By PharmaVoice Team • Nov. 15, 2014
PharmaVoice Team/PharmaVoice

R&D Crowdsourcing: Crowdsourcing in Pharma

Companies are looking at nontraditional ways of collaborating to access new insights that could lead to innovative therapies. There is a growing movement within the industry toward open access and crowdsourcing scientific information to accelerate research and development. This open environment r...
By Denise Myshko • Nov. 15, 2014
PharmaVoice Team/PharmaVoice

Augmented Reality: An Overlap Between the Virtual and the Real World

Augmented reality can take technology to a new level to improve patient outcomes and the healthcare journey. Augmented reality, the technology originally popularized as part of simulators and virtual reality games more than a decade ago, is gaining traction today in the pharma space. AR is relate...
By Taren Grom • Nov. 15, 2014